Classification of stimuli–responsive polymers as anticancer drug delivery systems
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Although several anticancer drugs have been introduced as chemotherapeutic agents, the effective treatment of cancer remains a challenge. Major limitations in the application of anticancer drugs include their nonspecificity, wide biodistribution, short half-life, low concentration in tumor tissue and systemic toxicity. Drug delivery to the tumor site has become feasible in recent years, and recent advances in the development of new drug delivery systems for controlled drug release in tumor tissues with reduced side effects show great promise. In this field, the use of biodegradable polymers as drug carriers has attracted the most attention. However, drug release is still difficult to control even when a polymeric drug carrier is used. The design of pharmaceutical polymers that respond to external stimuli (known as stimuli-responsive polymers) such as temperature, pH, electric or magnetic field, enzymes, ultrasound waves, etc. appears to be a successful approach. In these systems, drug release is triggered by different stimuli. The purpose of this review is to summarize different types of polymeric drug carriers and stimuli, in addition to the combination use of stimuli in order to achieve a better controlled drug release, and it discusses their potential strengths and applications. A survey of the recent literature on various stimuli-responsive drug delivery systems is also provided and perspectives on possible future developments in controlled drug release at tumor site have been discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 2×
“lead to the accumulation of polymer–drug conjugates at the tumor site (Maeda et al., 2000; Maeda et al., 2001; Kopecek et al., 2001; Abulateefeh et al., 2011).”
BackgroundMulti-Stimuli Sensitive Amphiphilic Block Copolymer Assemblies
Klaikherd, A., Nagamani, C., & Thayumanavan, S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809475a · Cited by 594
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Drug targeting using thermally responsive polymers and local hyperthermia
Meyer, D. E., Shin, B. C., Kong, G. A., Dewhirst, M. W., & Chilkoti, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00319-4 · Cited by 416 · cited 2×
“Thermosensitive delivery systems should have an LCST above body temperature, since hyperthermal treatment in patients with cancer is usually performed at 42 C (Meyer et al., 2001; Chaterji et al., 2007).”
BackgroundA Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
Lanza, G. M., Wallace, K. D., Scott, M. J., Cacheris, W. P., Abendschein, D. R., Christy, D. H., Sharkey, A. M., Miller, J. G., Gaffney, P. J., & Wickline, S. A. (1996) · Circulation · doi:10.1161/01.cir.94.12.3334 · Cited by 406 · cited 1×
“Site-specific actions of microtubules can also be achieved by attaching specific ligands (antibodies or peptides) to their surface (Lanza et al., 1996; Dayton et al., 2004).”
BackgroundThermosensitive and biodegradable polymeric micelles for paclitaxel delivery
Soga, O., van Nostrum, C. F., Fens, M., Rijcken, C. J. F., Schiffelers, R. M., Storm, G., & Hennink, W. E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.009 · Cited by 319 · cited 1×
“…(p(HPMAm-Lacn)) block which self-assembles into micellar structures in aqueous solution when heated above its critical micelle temperature (Soga et al., 2004, 2005; Rijcken et al., 2005, 2007; Van Nostrum et al., 2006; Talelli et al., 2010a). pH-sensitive polymers The lower extracellular…”
BackgroundThermo and pH Dual‐Responsive Nanoparticles for Anti‐Cancer Drug Delivery
Zhang, L., Guo, R., Yang, M., Jiang, X., & Liu, B. (2007) · Advanced Materials · doi:10.1002/adma.200601817 · Cited by 269 · cited 2×
“, 2005, 2007), paclitoxel-loaded P(NIPAAm-co-AA)-b-PCL NPs (Zhang et al., 2007), mPEG-b-P(HPMA-Lac-co-His), mPEG-b-PLA and cy5.”
BackgroundRanjan, A., Jacobs, G. C., Woods, D. L., Negussie, A. H., Partanen, A., Yarmolenko, P. S., Gacchina, C. E., Sharma, K. V., Frenkel, V., Wood, B. J., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.011 · Cited by 267 · cited 1×
“…(40–41 C) was applied to the tumors and thus triggered the release of doxorubicin from doxorubicin encapsulated low temperature sensitive liposomes (LTSLs); which resulted in higher drug accumulation in an experimental tumor model compared with nonirradiated controls (Ranjan et al., 2012).”
BackgroundSPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.009 · Cited by 182
Cited by
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.061 · Cited by 1,004
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Poly(N-isopropylacrylamide)-Based Thermoresponsive Composite Hydrogels for Biomedical Applications
Xu, X., Liu, Y., Fu, W., Yao, M., Ding, Z., Xuan, J., Li, D., Wang, S., Xia, Y., & Cao, M. (2020) · Polymers · doi:10.3390/polym12030580 · Cited by 402
pH ‐responsive polymers for drug delivery: Trends and opportunities
Singh, J., & Nayak, P. (2023) · Journal of Polymer Science · doi:10.1002/pol.20230403 · Cited by 327
Polymeric microneedles for transdermal protein delivery
Ye, Y., Yu, J., Wen, D., Kahkoska, A. R., & Gu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.015 · Cited by 324
Metadata
- Authors
- Taghizadeh, B., Taranejoo, S., Monemian, S. A., Salehi Moghaddam, Z., Daliri, K., Derakhshankhah, H., & Derakhshani, Z.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2014-02-19
- Volume
- 22
- Issue
- 2
- Pages
- 145-155
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2059446244
- Cited by
- 154
- References
- 12
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Classification of stimuli–responsive polymers as anticancer drug delivery systems. https://app.cochat.ai/papers/10.3109/10717544.2014.887157
- The paper
- Taghizadeh, B., Taranejoo, S., Monemian, S. A., Salehi Moghaddam, Z., Daliri, K., Derakhshankhah, H., & Derakhshani, Z. (2015). Classification of stimuli–responsive polymers as anticancer drug delivery systems. Drug Delivery. https://doi.org/10.3109/10717544.2014.887157
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.